pancreatic cancer glutathione enhancement

pancreatic cancer glutathione enhancement Targeting glutamine dependency confers vulnerability to GPX4-dependent ferroptosis: Cell Reports Medicine Leveraging glycosylation for early detection

Name: pancreatic cancer glutathione enhancement Targeting glutamine dependency confers vulnerability to GPX4-dependent ferroptosis: Cell Reports Medicine Leveraging glycosylation for early detection
Brand: webdevsolutions.tech
SKU: 13347396143
Price: 23.37 USD
Availability: InStock
Rating: 4.864000000000001 (8 reviews)

Leveraging glycosylation for early detection and therapeutic target discovery in pancreatic cancer Cell Death & Disease Novel drug therapy kills pancreatic cancer cells by reducing levels of antioxidants Cold Spring Harbor Laboratory Increased glucose availability sensitizes pancreatic cancer to chemotherapy bioRxiv Role of Glutathione in Cancer: From Mechanisms to Therapies PMC

SKU: 13347396143 · From webdevsolutions.tech

4.9

USD23.37 USD57.37

Pay in 4 interest-free payments of $5.84 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

High prolactin levels ( hyperprolactinemia ) can cause reproductive problems in both men and women

In a first-in-human clinical trial (NCT02491281), LNA043 was administered via intra-articular injection before total knee replacement, and results showed that LNA043 could reverse the transcriptome signature associated with osteoarthritis by promoting the expression of hyaline cartilage matrix components and anabolic signaling pathways [435]